RxDoctor Payments Data

Duane Johnson, DO

Family Medicine · Fort Wayne, INNPI 1750392676

Payments from drug & device makers

$2,135in general payments, 2019–2025

Across 153 payments — averaging $13.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$448
  • AstraZeneca$382
  • Axsome Therapeutics, Inc.$208
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$174
  • Corium, LLC$146
  • Pfizer$137
  • plus $640 from 13 others

What the payments were for

  • Food & beverage$2,12399%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,135 in reported general payments places this provider in the 70th percentile of 2,709 family medicine providers in Indiana.

See all family medicine providers in Indiana

Medicare billing

Part B allowed, 2024
$49,255
Medicare patients
196
Services billed
777

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban198$65,379
XareltoRivaroxaban108$56,897
JanuviaSitagliptin Phosphate89$48,110
FarxigaDapagliflozin Propanediol63$43,277
OzempicSemaglutide36$35,922
TrulicityDulaglutide26$33,595
JardianceEmpagliflozin47$29,095
MounjaroTirzepatide21$23,746
CreonLipase/Protease/Amylase18$19,062
RexultiBrexpiprazole27$15,129
Breo ElliptaFluticasone/Vilanterol33$13,911
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog47$11,824
GemtesaVibegron36$8,898
MyrbetriqMirabegron47$8,290
AbrysvoRsv Vacc, Pref A And Pref B/Pf26$8,168

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Abrysvo, Premarin$137$80,084241 claims
Lilly USA, LLCTrulicity, Mounjaro, Olanzapine$57$59,48789 claims
AstraZenecaFarxiga$382$43,27763 claims
Novo NordiskOzempic$122$35,92236 claims
AbbVieCreon$448$19,06218 claims
Otsuka America Pharmaceutical, Inc.Rexulti$16$15,12927 claims
Sumitomo Pharma America, Inc.Gemtesa$63$8,89836 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,709 family medicine providers in Indiana.

Other family medicine in Fort Wayne

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →